381 related articles for article (PubMed ID: 9430540)
1. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.
Amano S; Rohan R; Kuroki M; Tolentino M; Adamis AP
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):18-22. PubMed ID: 9430540
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
Philipp W; Speicher L; Humpel C
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2514-22. PubMed ID: 10937562
[TBL] [Abstract][Full Text] [Related]
3. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.
Edelman JL; Castro MR; Wen Y
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1112-23. PubMed ID: 10235544
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
[TBL] [Abstract][Full Text] [Related]
5. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
Ogata N; Wada M; Otsuji T; Jo N; Tombran-Tink J; Matsumura M
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1168-75. PubMed ID: 11923262
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of vascular endothelial growth factor in rat cornea after cautery with alkali].
Qiu P; Yao K; Zhu L; Zhou C; Cheng J
Zhonghua Yan Ke Za Zhi; 2002 May; 38(5):311-4. PubMed ID: 12133383
[TBL] [Abstract][Full Text] [Related]
7. Rapid ocular angiogenic control via naked DNA delivery to cornea.
Stechschulte SU; Joussen AM; von Recum HA; Poulaki V; Moromizato Y; Yuan J; D'Amato RJ; Kuo C; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1975-9. PubMed ID: 11481260
[TBL] [Abstract][Full Text] [Related]
8. The expression of nuclear factor kappa B in inflammation-induced rat corneal neovascularization.
Zhang MC; Wang Y; Yang Y
Ocul Immunol Inflamm; 2006 Dec; 14(6):359-65. PubMed ID: 17162607
[TBL] [Abstract][Full Text] [Related]
9. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.
Kvanta A; Sarman S; Fagerholm P; Seregard S; Steen B
Exp Eye Res; 2000 Apr; 70(4):419-28. PubMed ID: 10865990
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
12. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy.
Moore JE; McMullen TC; Campbell IL; Rohan R; Kaji Y; Afshari NA; Usui T; Archer DB; Adamis AP
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2905-15. PubMed ID: 12202509
[TBL] [Abstract][Full Text] [Related]
13. Insulin-induced vascular endothelial growth factor expression in retina.
Lu M; Amano S; Miyamoto K; Garland R; Keough K; Qin W; Adamis AP
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3281-6. PubMed ID: 10586954
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model.
Gong Y; Koh DR
Cell Tissue Res; 2010 Feb; 339(2):437-48. PubMed ID: 20012648
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing.
Gan L; Fagerholm P; Palmblad J
Acta Ophthalmol Scand; 2004 Oct; 82(5):557-63. PubMed ID: 15453853
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
17. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
Zuo L; Fan Y; Wang F; Gu Q; Xu X
Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas.
Lambiase A; Manni L; Bonini S; Rama P; Micera A; Aloe L
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1063-9. PubMed ID: 10752942
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes.
Kim I; Ryan AM; Rohan R; Amano S; Agular S; Miller JW; Adamis AP
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2115-21. PubMed ID: 10440268
[TBL] [Abstract][Full Text] [Related]
20. A model of angiogenesis in the mouse cornea.
Kenyon BM; Voest EE; Chen CC; Flynn E; Folkman J; D'Amato RJ
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1625-32. PubMed ID: 8675406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
